CRISPR plants won't be regulated
Posted by btwatson on March 29, 2018 4:40 pm
Tags:
Categories:
Crispr Articles
Source: CRISPR plants won't be regulated

In a big win for the biotech industry, the US Department of Agriculture says it won’t regulate plants whose genomes have been altered using gene-editing technology.
Why it’s a field day: The decision means that we could see a boom in newfangled plants from firms like Monsanto, universities, and startups like Calyxt, whose oil-altered soybeans featured in our cover story late last year.
What changed? Under President Obama, the USDA laid out plans to regulate genetically edited plants for safety. But the Trump administration scuttled those rules. Now the USDA says these plants pose “no risk.”
Here’s the logic: The USDA says gene editing is just a (much) faster form of breeding. So long as a genetic alteration could have been bred into a plant, it won’t be regulated. That includes changes that create immunity to disease or natural resistance to crop chemicals, as well as edits to make seeds bigger and heavier. It doesn’t include transgenic plants (those with a gene from a distant species)—those will still be regulated.
Problems ahead: Trade in major crops is a global affair. Unless Europe and China agree with the US, exports of CRISPR plants could yet be blocked.
Image credit:
- ThiloBecker | Pixababy
Published at Thu, 29 Mar 2018 15:56:34 +0000
Crispr News
-
ERS Genomics and NUVISAN ICB Sign CRISPR/Cas9 License Agreement - BioSpaceApril 19, 2021
-
Novel CRISPR tool allows unprecedented control of epigenetic inheritance - Health EuropaApril 19, 2021
-
New "Time Machine" Technique To Measure Cells Unveiled - Technology NetworksApril 19, 2021
-
GE probiotic? CRISPR-edited yeast produce vitamin A precursor beta-carotene - Genetic Literacy ProjectApril 19, 2021
-
CRISPR: Can we control it? - Big ThinkApril 18, 2021
-
Technological Trends in CRISPR/Cas9 Market by 2021-2027 – Los Hijos de la Malinche - Los Hijos de la MalincheApril 17, 2021
-
‘The Code Breaker’ review: The quest to rewrite DNA - The HinduApril 17, 2021
-
CRISPR Gene Editing Tools Market to See Strong Expansion Through 2027 Covid-19 Analysis – KSU | The Sentinel Newspaper - KSU | The Sentinel NewspaperApril 17, 2021
-
CRISPR Stocks: The Big Analyst Call Destroying CRSP, NTLA, EDIT Stocks Today - NasdaqApril 16, 2021
-
Reversible CRISPR: An on-off switch for gene editing - ScienceBlog.comApril 16, 2021
-
Global CRISPR Genome Editing Market SWOT Analysis, Key Indicators, Forecast 2027 : Editas Medicine, CRISPR Therapeutics AG – The Courier - The CourierApril 16, 2021
-
Precision’s itinerant Car-T cells go on another journey - VantageApril 16, 2021
-
CRISPR Technology Market Restraints, Overview Highlighting Major Drivers, Trends, Growth and Demand Report 2020- 2027 – KSU | The Sentinel Newspaper - KSU | The Sentinel NewspaperApril 16, 2021
-
Crispr And Cas Genes Market to Grow with Sustainable CAGR During 2020 – 2027 | Key Players – CRISPR Therapeutics, Genscrip, AstraZeneca. – KSU | The Sentinel Newspaper - KSU | The Sentinel NewspaperApril 16, 2021
-
World CRISPR Gene Detection and Diagnostic Markets 2021-2025: Market has Just Gotten Started with a Handful of Small Startups - Expect the Big Players to Start Taking Notice - GlobeNewswireApril 16, 2021
- CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
- CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
- The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
- The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
- ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
- The Dark Side of CRISPR – Scientific American
- ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
- Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
- DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
- CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
- Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
- New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
- After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
Leave a Reply
You must be logged in to post a comment.